nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.19	0.347	CbGbCtD
Droperidol—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.182	0.333	CbGbCtD
Droperidol—DRD2—Bromocriptine—type 2 diabetes mellitus	0.175	0.32	CbGbCtD
Droperidol—HTR2A—arteriole—type 2 diabetes mellitus	0.0128	0.203	CbGeAlD
Droperidol—Hyperprolactinaemia—Bromocriptine—type 2 diabetes mellitus	0.00939	0.038	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Tolbutamide—type 2 diabetes mellitus	0.00909	0.0368	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Tolazamide—type 2 diabetes mellitus	0.00827	0.0335	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Chlorpropamide—type 2 diabetes mellitus	0.00827	0.0335	CcSEcCtD
Droperidol—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00817	0.129	CbGeAlD
Droperidol—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00549	0.087	CbGeAlD
Droperidol—Inappropriate antidiuretic hormone secretion—Glipizide—type 2 diabetes mellitus	0.00548	0.0222	CcSEcCtD
Droperidol—Neuroleptic malignant syndrome—Bromocriptine—type 2 diabetes mellitus	0.00524	0.0212	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Glimepiride—type 2 diabetes mellitus	0.00512	0.0207	CcSEcCtD
Droperidol—HTR2A—hindlimb—type 2 diabetes mellitus	0.00508	0.0805	CbGeAlD
Droperidol—DRD2—nerve—type 2 diabetes mellitus	0.00468	0.0742	CbGeAlD
Droperidol—Inappropriate antidiuretic hormone secretion—Glyburide—type 2 diabetes mellitus	0.00422	0.0171	CcSEcCtD
Droperidol—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00396	0.0628	CbGeAlD
Droperidol—HTR2A—artery—type 2 diabetes mellitus	0.00311	0.0493	CbGeAlD
Droperidol—HTR2A—nerve—type 2 diabetes mellitus	0.00309	0.049	CbGeAlD
Droperidol—Ventricular tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00268	0.0109	CcSEcCtD
Droperidol—HTR2A—endothelium—type 2 diabetes mellitus	0.00263	0.0417	CbGeAlD
Droperidol—Inappropriate antidiuretic hormone secretion—Ramipril—type 2 diabetes mellitus	0.00241	0.00977	CcSEcCtD
Droperidol—Ventricular arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00235	0.00951	CcSEcCtD
Droperidol—Amenorrhoea—Orlistat—type 2 diabetes mellitus	0.00228	0.00921	CcSEcCtD
Droperidol—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.00224	0.0354	CbGeAlD
Droperidol—Blood pressure increased—Gliclazide—type 2 diabetes mellitus	0.0022	0.00891	CcSEcCtD
Droperidol—Hyperglycaemia—Repaglinide—type 2 diabetes mellitus	0.00218	0.00882	CcSEcCtD
Droperidol—Hyperglycaemia—Rosiglitazone—type 2 diabetes mellitus	0.00206	0.00834	CcSEcCtD
Droperidol—Pimozide—CALM1—type 2 diabetes mellitus	0.00203	0.252	CrCbGaD
Droperidol—Blood pressure increased—Valsartan—type 2 diabetes mellitus	0.00202	0.00819	CcSEcCtD
Droperidol—DRD2—retina—type 2 diabetes mellitus	0.00194	0.0307	CbGeAlD
Droperidol—Angioedema—Linagliptin—type 2 diabetes mellitus	0.0019	0.00769	CcSEcCtD
Droperidol—Laryngospasm—Ramipril—type 2 diabetes mellitus	0.00188	0.00761	CcSEcCtD
Droperidol—Drowsiness—Glipizide—type 2 diabetes mellitus	0.00178	0.00721	CcSEcCtD
Droperidol—Blood pressure increased—Irbesartan—type 2 diabetes mellitus	0.00174	0.00704	CcSEcCtD
Droperidol—Hyperglycaemia—Pioglitazone—type 2 diabetes mellitus	0.00173	0.00699	CcSEcCtD
Droperidol—Palpitations—Nateglinide—type 2 diabetes mellitus	0.00172	0.00696	CcSEcCtD
Droperidol—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.0017	0.00686	CcSEcCtD
Droperidol—Hyperglycaemia—Sitagliptin—type 2 diabetes mellitus	0.00168	0.00679	CcSEcCtD
Droperidol—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.00167	0.0265	CbGeAlD
Droperidol—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.00166	0.00673	CcSEcCtD
Droperidol—Depression—Sitagliptin—type 2 diabetes mellitus	0.00165	0.00669	CcSEcCtD
Droperidol—Ventricular tachycardia—Losartan—type 2 diabetes mellitus	0.00164	0.00662	CcSEcCtD
Droperidol—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.00162	0.0256	CbGeAlD
Droperidol—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.0015	0.00607	CcSEcCtD
Droperidol—Palpitations—Repaglinide—type 2 diabetes mellitus	0.00149	0.00602	CcSEcCtD
Droperidol—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.00148	0.0234	CbGeAlD
Droperidol—Angioedema—Rosiglitazone—type 2 diabetes mellitus	0.00145	0.00589	CcSEcCtD
Droperidol—Hypertension—Repaglinide—type 2 diabetes mellitus	0.00145	0.00588	CcSEcCtD
Droperidol—Chills—Glipizide—type 2 diabetes mellitus	0.00144	0.00581	CcSEcCtD
Droperidol—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00137	0.00556	CcSEcCtD
Droperidol—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.00137	0.00556	CcSEcCtD
Droperidol—Hallucination—Bromocriptine—type 2 diabetes mellitus	0.00134	0.00543	CcSEcCtD
Droperidol—Rash—Miglitol—type 2 diabetes mellitus	0.00132	0.00535	CcSEcCtD
Droperidol—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00132	0.00534	CcSEcCtD
Droperidol—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.0013	0.00526	CcSEcCtD
Droperidol—HTR2A—retina—type 2 diabetes mellitus	0.00128	0.0203	CbGeAlD
Droperidol—Gynaecomastia—Ramipril—type 2 diabetes mellitus	0.00126	0.00508	CcSEcCtD
Droperidol—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00125	0.00506	CcSEcCtD
Droperidol—Syncope—Glipizide—type 2 diabetes mellitus	0.00125	0.00506	CcSEcCtD
Droperidol—Hyperglycaemia—Gliclazide—type 2 diabetes mellitus	0.00125	0.00504	CcSEcCtD
Droperidol—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00123	0.00499	CcSEcCtD
Droperidol—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.00123	0.00499	CcSEcCtD
Droperidol—Depression—Gliclazide—type 2 diabetes mellitus	0.00123	0.00497	CcSEcCtD
Droperidol—Fluspirilene—ADRA2A—type 2 diabetes mellitus	0.00123	0.153	CrCbGaD
Droperidol—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.00122	0.00496	CcSEcCtD
Droperidol—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.00122	0.00494	CcSEcCtD
Droperidol—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00121	0.00491	CcSEcCtD
Droperidol—Hypertension—Glipizide—type 2 diabetes mellitus	0.0012	0.00487	CcSEcCtD
Droperidol—Angioedema—Glimepiride—type 2 diabetes mellitus	0.00119	0.00481	CcSEcCtD
Droperidol—Rash—Tolbutamide—type 2 diabetes mellitus	0.00119	0.00481	CcSEcCtD
Droperidol—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.00118	0.00479	CcSEcCtD
Droperidol—Anxiety—Glipizide—type 2 diabetes mellitus	0.00118	0.00478	CcSEcCtD
Droperidol—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00117	0.00473	CcSEcCtD
Droperidol—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.00115	0.00466	CcSEcCtD
Droperidol—Palpitations—Glimepiride—type 2 diabetes mellitus	0.00115	0.00465	CcSEcCtD
Droperidol—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.00114	0.00462	CcSEcCtD
Droperidol—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00113	0.00459	CcSEcCtD
Droperidol—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00113	0.00459	CcSEcCtD
Droperidol—Hypertension—Glimepiride—type 2 diabetes mellitus	0.00112	0.00454	CcSEcCtD
Droperidol—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.00112	0.00453	CcSEcCtD
Droperidol—Shock—Glipizide—type 2 diabetes mellitus	0.00112	0.00453	CcSEcCtD
Droperidol—Depression—Orlistat—type 2 diabetes mellitus	0.00112	0.00451	CcSEcCtD
Droperidol—Anxiety—Glimepiride—type 2 diabetes mellitus	0.0011	0.00446	CcSEcCtD
Droperidol—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.0011	0.00445	CcSEcCtD
Droperidol—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00109	0.00441	CcSEcCtD
Droperidol—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.00108	0.0171	CbGeAlD
Droperidol—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00108	0.00437	CcSEcCtD
Droperidol—Rash—Tolazamide—type 2 diabetes mellitus	0.00108	0.00437	CcSEcCtD
Droperidol—Rash—Linagliptin—type 2 diabetes mellitus	0.00107	0.00433	CcSEcCtD
Droperidol—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00107	0.00432	CcSEcCtD
Droperidol—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00106	0.00429	CcSEcCtD
Droperidol—HTR2A—kidney—type 2 diabetes mellitus	0.00106	0.0168	CbGeAlD
Droperidol—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00106	0.00428	CcSEcCtD
Droperidol—Syncope—Bromocriptine—type 2 diabetes mellitus	0.00105	0.00426	CcSEcCtD
Droperidol—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00105	0.00425	CcSEcCtD
Droperidol—Shock—Glimepiride—type 2 diabetes mellitus	0.00104	0.00422	CcSEcCtD
Droperidol—Rash—Acarbose—type 2 diabetes mellitus	0.00104	0.0042	CcSEcCtD
Droperidol—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00104	0.0042	CcSEcCtD
Droperidol—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00104	0.00419	CcSEcCtD
Droperidol—ADRA1A—liver—type 2 diabetes mellitus	0.00104	0.0164	CbGeAlD
Droperidol—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.00103	0.00417	CcSEcCtD
Droperidol—Drowsiness—Metformin—type 2 diabetes mellitus	0.00103	0.00417	CcSEcCtD
Droperidol—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00101	0.0041	CcSEcCtD
Droperidol—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00101	0.0041	CcSEcCtD
Droperidol—Somnolence—Glipizide—type 2 diabetes mellitus	0.00101	0.00409	CcSEcCtD
Droperidol—Rash—Nateglinide—type 2 diabetes mellitus	0.001	0.00405	CcSEcCtD
Droperidol—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.001	0.00405	CcSEcCtD
Droperidol—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000995	0.00403	CcSEcCtD
Droperidol—Chills—Gliclazide—type 2 diabetes mellitus	0.000992	0.00402	CcSEcCtD
Droperidol—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000991	0.00401	CcSEcCtD
Droperidol—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000984	0.00398	CcSEcCtD
Droperidol—Angioedema—Glyburide—type 2 diabetes mellitus	0.00098	0.00396	CcSEcCtD
Droperidol—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000943	0.00382	CcSEcCtD
Droperidol—Shock—Bromocriptine—type 2 diabetes mellitus	0.000942	0.00381	CcSEcCtD
Droperidol—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00094	0.00381	CcSEcCtD
Droperidol—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000934	0.00378	CcSEcCtD
Droperidol—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000926	0.00375	CcSEcCtD
Droperidol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000894	0.00362	CcSEcCtD
Droperidol—Angioedema—Gliclazide—type 2 diabetes mellitus	0.00088	0.00356	CcSEcCtD
Droperidol—Rash—Repaglinide—type 2 diabetes mellitus	0.000866	0.00351	CcSEcCtD
Droperidol—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000866	0.0035	CcSEcCtD
Droperidol—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000866	0.0035	CcSEcCtD
Droperidol—Shock—Glyburide—type 2 diabetes mellitus	0.000861	0.00348	CcSEcCtD
Droperidol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000859	0.00348	CcSEcCtD
Droperidol—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000851	0.00344	CcSEcCtD
Droperidol—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000851	0.00344	CcSEcCtD
Droperidol—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000846	0.00342	CcSEcCtD
Droperidol—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000838	0.00339	CcSEcCtD
Droperidol—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000831	0.00336	CcSEcCtD
Droperidol—Chills—Metformin—type 2 diabetes mellitus	0.00083	0.00336	CcSEcCtD
Droperidol—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000819	0.00331	CcSEcCtD
Droperidol—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000818	0.00331	CcSEcCtD
Droperidol—Hypotension—Glyburide—type 2 diabetes mellitus	0.000818	0.00331	CcSEcCtD
Droperidol—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000817	0.00331	CcSEcCtD
Droperidol—Fenbufen—PTGS2—type 2 diabetes mellitus	0.000814	0.101	CrCbGaD
Droperidol—Angioedema—Valsartan—type 2 diabetes mellitus	0.000808	0.00327	CcSEcCtD
Droperidol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000802	0.00325	CcSEcCtD
Droperidol—Angioedema—Orlistat—type 2 diabetes mellitus	0.000799	0.00323	CcSEcCtD
Droperidol—Syncope—Valsartan—type 2 diabetes mellitus	0.000793	0.00321	CcSEcCtD
Droperidol—Chills—Irbesartan—type 2 diabetes mellitus	0.000783	0.00317	CcSEcCtD
Droperidol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000782	0.00316	CcSEcCtD
Droperidol—Palpitations—Valsartan—type 2 diabetes mellitus	0.000782	0.00316	CcSEcCtD
Droperidol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000779	0.00315	CcSEcCtD
Droperidol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000777	0.00315	CcSEcCtD
Droperidol—Palpitations—Orlistat—type 2 diabetes mellitus	0.000772	0.00313	CcSEcCtD
Droperidol—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000767	0.0031	CcSEcCtD
Droperidol—Domperidone—CYP1A2—type 2 diabetes mellitus	0.000763	0.095	CrCbGaD
Droperidol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000757	0.00306	CcSEcCtD
Droperidol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000752	0.00304	CcSEcCtD
Droperidol—Anxiety—Valsartan—type 2 diabetes mellitus	0.00075	0.00304	CcSEcCtD
Droperidol—Anxiety—Orlistat—type 2 diabetes mellitus	0.000742	0.003	CcSEcCtD
Droperidol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000734	0.00297	CcSEcCtD
Droperidol—Syncope—Metformin—type 2 diabetes mellitus	0.000722	0.00292	CcSEcCtD
Droperidol—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000722	0.00292	CcSEcCtD
Droperidol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00072	0.00292	CcSEcCtD
Droperidol—Rash—Glipizide—type 2 diabetes mellitus	0.000717	0.0029	CcSEcCtD
Droperidol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000716	0.0029	CcSEcCtD
Droperidol—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000713	0.00289	CcSEcCtD
Droperidol—Palpitations—Metformin—type 2 diabetes mellitus	0.000712	0.00288	CcSEcCtD
Droperidol—Shock—Valsartan—type 2 diabetes mellitus	0.00071	0.00287	CcSEcCtD
Droperidol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000708	0.00287	CcSEcCtD
Droperidol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000702	0.00284	CcSEcCtD
Droperidol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000699	0.00283	CcSEcCtD
Droperidol—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000699	0.00283	CcSEcCtD
Droperidol—Hypertension—Metformin—type 2 diabetes mellitus	0.000695	0.00281	CcSEcCtD
Droperidol—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000695	0.00281	CcSEcCtD
Droperidol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000682	0.00276	CcSEcCtD
Droperidol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000675	0.00273	CcSEcCtD
Droperidol—Pimozide—CYP2E1—type 2 diabetes mellitus	0.00067	0.0834	CrCbGaD
Droperidol—HTR2A—liver—type 2 diabetes mellitus	0.000669	0.0106	CbGeAlD
Droperidol—Rash—Glimepiride—type 2 diabetes mellitus	0.000669	0.00271	CcSEcCtD
Droperidol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000668	0.00271	CcSEcCtD
Droperidol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000668	0.0027	CcSEcCtD
Droperidol—Rash—Sitagliptin—type 2 diabetes mellitus	0.000667	0.0027	CcSEcCtD
Droperidol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000666	0.0027	CcSEcCtD
Droperidol—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000656	0.00266	CcSEcCtD
Droperidol—Angioedema—Losartan—type 2 diabetes mellitus	0.000654	0.00265	CcSEcCtD
Droperidol—Shock—Metformin—type 2 diabetes mellitus	0.000647	0.00262	CcSEcCtD
Droperidol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000645	0.00261	CcSEcCtD
Droperidol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000645	0.00261	CcSEcCtD
Droperidol—Somnolence—Valsartan—type 2 diabetes mellitus	0.000642	0.0026	CcSEcCtD
Droperidol—Syncope—Losartan—type 2 diabetes mellitus	0.000642	0.0026	CcSEcCtD
Droperidol—Pimozide—CYP1A2—type 2 diabetes mellitus	0.000637	0.0793	CrCbGaD
Droperidol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000633	0.00256	CcSEcCtD
Droperidol—Palpitations—Losartan—type 2 diabetes mellitus	0.000632	0.00256	CcSEcCtD
Droperidol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000629	0.00254	CcSEcCtD
Droperidol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000621	0.00251	CcSEcCtD
Droperidol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00062	0.00251	CcSEcCtD
Droperidol—Hypotension—Metformin—type 2 diabetes mellitus	0.000614	0.00249	CcSEcCtD
Droperidol—Shock—Irbesartan—type 2 diabetes mellitus	0.00061	0.00247	CcSEcCtD
Droperidol—Anxiety—Losartan—type 2 diabetes mellitus	0.000607	0.00246	CcSEcCtD
Droperidol—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000605	0.00245	CcSEcCtD
Droperidol—Rash—Bromocriptine—type 2 diabetes mellitus	0.000604	0.00244	CcSEcCtD
Droperidol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000603	0.00244	CcSEcCtD
Droperidol—Somnolence—Metformin—type 2 diabetes mellitus	0.000584	0.00237	CcSEcCtD
Droperidol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000584	0.00236	CcSEcCtD
Droperidol—Haloperidol—CYP1A2—type 2 diabetes mellitus	0.000582	0.0724	CrCbGaD
Droperidol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00058	0.00235	CcSEcCtD
Droperidol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000579	0.00234	CcSEcCtD
Droperidol—Shock—Losartan—type 2 diabetes mellitus	0.000574	0.00232	CcSEcCtD
Droperidol—Tachycardia—Losartan—type 2 diabetes mellitus	0.00057	0.00231	CcSEcCtD
Droperidol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000564	0.00228	CcSEcCtD
Droperidol—Angioedema—Ramipril—type 2 diabetes mellitus	0.00056	0.00227	CcSEcCtD
Droperidol—Rash—Glyburide—type 2 diabetes mellitus	0.000552	0.00223	CcSEcCtD
Droperidol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000552	0.00223	CcSEcCtD
Droperidol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000551	0.00223	CcSEcCtD
Droperidol—Syncope—Ramipril—type 2 diabetes mellitus	0.00055	0.00223	CcSEcCtD
Droperidol—Hypotension—Losartan—type 2 diabetes mellitus	0.000546	0.00221	CcSEcCtD
Droperidol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000542	0.00219	CcSEcCtD
Droperidol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000539	0.00218	CcSEcCtD
Droperidol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000532	0.00215	CcSEcCtD
Droperidol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000526	0.00213	CcSEcCtD
Droperidol—Anxiety—Ramipril—type 2 diabetes mellitus	0.00052	0.00211	CcSEcCtD
Droperidol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00052	0.0021	CcSEcCtD
Droperidol—Somnolence—Losartan—type 2 diabetes mellitus	0.000519	0.0021	CcSEcCtD
Droperidol—Domperidone—CYP3A4—type 2 diabetes mellitus	0.000505	0.0629	CrCbGaD
Droperidol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000501	0.00203	CcSEcCtD
Droperidol—Rash—Gliclazide—type 2 diabetes mellitus	0.000495	0.002	CcSEcCtD
Droperidol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000495	0.002	CcSEcCtD
Droperidol—Shock—Ramipril—type 2 diabetes mellitus	0.000493	0.00199	CcSEcCtD
Droperidol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00049	0.00198	CcSEcCtD
Droperidol—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000489	0.00198	CcSEcCtD
Droperidol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000477	0.00193	CcSEcCtD
Droperidol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000472	0.00191	CcSEcCtD
Droperidol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000468	0.00189	CcSEcCtD
Droperidol—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000462	0.00187	CcSEcCtD
Droperidol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000457	0.00185	CcSEcCtD
Droperidol—Rash—Valsartan—type 2 diabetes mellitus	0.000455	0.00184	CcSEcCtD
Droperidol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000455	0.00184	CcSEcCtD
Droperidol—Rash—Orlistat—type 2 diabetes mellitus	0.00045	0.00182	CcSEcCtD
Droperidol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000449	0.00182	CcSEcCtD
Droperidol—Somnolence—Ramipril—type 2 diabetes mellitus	0.000445	0.0018	CcSEcCtD
Droperidol—Dizziness—Metformin—type 2 diabetes mellitus	0.000435	0.00176	CcSEcCtD
Droperidol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00043	0.00174	CcSEcCtD
Droperidol—Pimozide—CYP3A4—type 2 diabetes mellitus	0.000422	0.0525	CrCbGaD
Droperidol—Rash—Metformin—type 2 diabetes mellitus	0.000414	0.00168	CcSEcCtD
Droperidol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000414	0.00168	CcSEcCtD
Droperidol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00041	0.00166	CcSEcCtD
Droperidol—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000396	0.0016	CcSEcCtD
Droperidol—Rash—Irbesartan—type 2 diabetes mellitus	0.000391	0.00158	CcSEcCtD
Droperidol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000391	0.00158	CcSEcCtD
Droperidol—Dizziness—Losartan—type 2 diabetes mellitus	0.000386	0.00156	CcSEcCtD
Droperidol—Haloperidol—CYP3A4—type 2 diabetes mellitus	0.000385	0.0479	CrCbGaD
Droperidol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000369	0.00149	CcSEcCtD
Droperidol—Rash—Losartan—type 2 diabetes mellitus	0.000368	0.00149	CcSEcCtD
Droperidol—Dermatitis—Losartan—type 2 diabetes mellitus	0.000368	0.00149	CcSEcCtD
Droperidol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000331	0.00134	CcSEcCtD
Droperidol—Rash—Ramipril—type 2 diabetes mellitus	0.000316	0.00128	CcSEcCtD
Droperidol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000315	0.00128	CcSEcCtD
Droperidol—HTR2A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.78e-05	0.000281	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	3.77e-05	0.000281	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.74e-05	0.000279	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.72e-05	0.000277	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.72e-05	0.000277	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AVP—type 2 diabetes mellitus	3.72e-05	0.000277	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	3.72e-05	0.000277	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	3.71e-05	0.000276	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.7e-05	0.000275	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.67e-05	0.000273	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.66e-05	0.000273	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.61e-05	0.000269	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.61e-05	0.000269	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.55e-05	0.000265	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.53e-05	0.000263	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.53e-05	0.000263	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.48e-05	0.00026	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.48e-05	0.000259	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.47e-05	0.000259	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.45e-05	0.000257	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.43e-05	0.000255	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.42e-05	0.000255	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INSR—type 2 diabetes mellitus	3.4e-05	0.000254	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.4e-05	0.000253	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.39e-05	0.000253	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.37e-05	0.000251	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.36e-05	0.00025	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.35e-05	0.00025	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INSR—type 2 diabetes mellitus	3.35e-05	0.000249	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.34e-05	0.000249	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.34e-05	0.000249	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.32e-05	0.000248	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.32e-05	0.000247	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.3e-05	0.000246	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.3e-05	0.000246	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.29e-05	0.000245	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.29e-05	0.000245	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.28e-05	0.000244	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INSR—type 2 diabetes mellitus	3.28e-05	0.000244	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.27e-05	0.000244	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.23e-05	0.000241	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.23e-05	0.00024	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.22e-05	0.00024	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.22e-05	0.00024	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—C3—type 2 diabetes mellitus	3.2e-05	0.000239	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.2e-05	0.000239	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.18e-05	0.000237	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.16e-05	0.000235	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—C3—type 2 diabetes mellitus	3.15e-05	0.000235	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.13e-05	0.000233	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.1e-05	0.000231	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.09e-05	0.00023	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.09e-05	0.00023	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—C3—type 2 diabetes mellitus	3.09e-05	0.00023	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.07e-05	0.000229	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.05e-05	0.000227	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.04e-05	0.000227	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.04e-05	0.000227	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.04e-05	0.000227	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.01e-05	0.000224	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	3e-05	0.000223	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.99e-05	0.000223	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.99e-05	0.000223	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.98e-05	0.000222	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.98e-05	0.000222	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.98e-05	0.000222	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.96e-05	0.00022	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.95e-05	0.000219	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.94e-05	0.000219	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.94e-05	0.000219	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.93e-05	0.000219	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.93e-05	0.000218	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.93e-05	0.000218	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.9e-05	0.000216	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.89e-05	0.000216	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.89e-05	0.000216	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.88e-05	0.000215	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.88e-05	0.000215	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.88e-05	0.000215	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.88e-05	0.000215	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.85e-05	0.000212	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.83e-05	0.000211	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.82e-05	0.00021	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.82e-05	0.00021	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.81e-05	0.00021	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.79e-05	0.000208	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.77e-05	0.000206	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.73e-05	0.000203	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.71e-05	0.000202	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.71e-05	0.000202	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.68e-05	0.0002	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.68e-05	0.0002	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.68e-05	0.0002	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.67e-05	0.000199	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GCG—type 2 diabetes mellitus	2.64e-05	0.000196	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.64e-05	0.000196	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.64e-05	0.000196	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.63e-05	0.000196	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.63e-05	0.000196	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.61e-05	0.000195	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.59e-05	0.000193	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.59e-05	0.000193	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.58e-05	0.000192	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	2.58e-05	0.000192	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.54e-05	0.000189	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.53e-05	0.000189	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.51e-05	0.000187	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.47e-05	0.000184	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.46e-05	0.000184	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.46e-05	0.000183	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.42e-05	0.000181	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.42e-05	0.00018	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.42e-05	0.00018	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.37e-05	0.000177	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.37e-05	0.000177	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.33e-05	0.000174	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.31e-05	0.000172	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.29e-05	0.000171	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.28e-05	0.00017	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.28e-05	0.00017	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.27e-05	0.000169	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.27e-05	0.000169	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.26e-05	0.000168	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.25e-05	0.000167	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.24e-05	0.000167	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.24e-05	0.000167	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.23e-05	0.000167	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.23e-05	0.000166	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.22e-05	0.000166	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.22e-05	0.000166	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.2e-05	0.000164	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.2e-05	0.000164	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.19e-05	0.000164	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.19e-05	0.000164	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.19e-05	0.000163	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.19e-05	0.000163	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.18e-05	0.000162	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.17e-05	0.000161	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.17e-05	0.000161	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.16e-05	0.000161	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.15e-05	0.00016	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.13e-05	0.000159	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.12e-05	0.000158	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.11e-05	0.000157	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.1e-05	0.000157	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.09e-05	0.000156	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.07e-05	0.000154	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.06e-05	0.000153	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.03e-05	0.000151	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.03e-05	0.000151	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.98e-05	0.000148	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.97e-05	0.000147	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.94e-05	0.000145	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.94e-05	0.000144	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.91e-05	0.000142	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.9e-05	0.000142	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	1.89e-05	0.000141	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.87e-05	0.000139	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	1.86e-05	0.000139	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	1.82e-05	0.000136	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.81e-05	0.000135	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.8e-05	0.000134	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.8e-05	0.000134	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.78e-05	0.000132	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.77e-05	0.000132	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.77e-05	0.000132	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.77e-05	0.000132	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.76e-05	0.000131	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.76e-05	0.000131	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.74e-05	0.00013	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.74e-05	0.00013	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.74e-05	0.00013	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.73e-05	0.000129	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.73e-05	0.000129	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.73e-05	0.000129	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.73e-05	0.000129	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.71e-05	0.000128	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.7e-05	0.000127	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.7e-05	0.000127	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.7e-05	0.000127	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.68e-05	0.000125	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.66e-05	0.000124	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.64e-05	0.000122	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.6e-05	0.000119	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.57e-05	0.000117	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.55e-05	0.000115	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.51e-05	0.000113	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	1.51e-05	0.000112	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.48e-05	0.00011	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.48e-05	0.00011	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.46e-05	0.000109	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.46e-05	0.000109	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.46e-05	0.000108	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.45e-05	0.000108	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.45e-05	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.43e-05	0.000107	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.43e-05	0.000107	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.43e-05	0.000106	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.43e-05	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.4e-05	0.000105	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.4e-05	0.000104	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.4e-05	0.000104	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.38e-05	0.000103	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.36e-05	0.000101	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.33e-05	9.93e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.32e-05	9.84e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.32e-05	9.84e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.3e-05	9.68e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.3e-05	9.68e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.27e-05	9.48e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.27e-05	9.48e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.24e-05	9.26e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.22e-05	9.11e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.2e-05	8.92e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.13e-05	8.43e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.12e-05	8.35e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.11e-05	8.3e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.11e-05	8.29e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.1e-05	8.22e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.1e-05	8.16e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.09e-05	8.12e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.08e-05	8.05e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.07e-05	7.99e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.06e-05	7.89e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.05e-05	7.81e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-05	7.77e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-05	7.68e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.03e-05	7.66e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.02e-05	7.6e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-05	7.53e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-05	7.52e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.9e-06	7.38e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.77e-06	7.28e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.61e-06	7.16e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.51e-06	7.09e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.41e-06	7.01e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.36e-06	6.97e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.16e-06	6.83e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.73e-06	6.5e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.59e-06	6.4e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.56e-06	6.38e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.42e-06	6.28e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.41e-06	6.27e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.25e-06	6.14e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.58e-06	4.9e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.47e-06	4.82e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.34e-06	4.72e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.07e-06	4.52e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.97e-06	4.45e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.85e-06	4.36e-05	CbGpPWpGaD
